[tt] 50% Maximum Life Extension in Mice Via p53 and Telomerase
Brian Atkins
<brian at posthuman.com> on
Tue Jan 29 05:14:46 UTC 2008
http://www.fightaging.org/archives/001403.php
My attention was drawn to a Spanish article on one of the many research groups
investigating the role of p53 in aging and cancer. There has been a great deal
of interest in finding ways around the "cancer or aging, choose one" limitation
to this set of biochemical mechanisms, thought to apply until recently. This
Spanish article is somewhat in advance of the scientific publication; I'm not
sure why that is the case.
The translation via Google is fair (suggestions taken on a better translation
automaton):
In this line, Serrano said that the genomes of a chimpanzee and humans are
virtually identical at 99.8%. However, the maximum life of a chimpanzee is 60
years and the human rarely exceeds 110. The average of a chimpanzee is 40 years
and that of a human, 80. There must be something in our genes very subtle
changes made to live 50 years to live 100. Then, along with the team of Mary
Blasco, we are going to make some genetic manipulation to see if we can increase
longevity in mice much more. That is our challenge If we get a mouse in the
privileged environment of a laboratory comes to live three years to live six
passes, it would be proof that longevity is flexible and would know how to
enlarge it.
So it seems compelled to ask the molecular biologist in this battle if they
have undertaken together against cancer and aging, it is just a matter of
putting telomerase a mouse to make it immortal. The answer is no, because
telomerase makes more cancer. To ensure a tumor, which has activated telomerase,
and if a mouse has more telomerase than normal, for example, on transgenic mice,
we know that you have more tumors. What we have done is to use the superratones
Manuel, because p53 protects cancer and a 18% lengthens the life of mice, and if
we add to this the gene of immortality, telomerase, which got these mice [to]
live an average of 50% more, without cancer, which are words older. That is what
we have discovered now.
Because this extension of life, 50% in superratones is the longest that has
been described in mammals.
You get the gist, despite the breakdown of translation in the last few
sentences: there are combinations of metabolic and genetic states in mammals not
selected for by evolution that nonetheless lead to a clearly superior beast,
from our perspective at least. Well, more or less. If you head over to the
Methuselah Foundation forums, you'll find that Michael Rae wrote a long piece on
this research back in mid-2007, before the life span studies were complete:
The standard reading is that the "Super p53" mice are getting less cancer,
but are having their [life spans] restrained by lack of tissue replenishment due
to stem cell loss, while the telomerase transgenics are on the opposite horn of
the same dilemma. It seems at least possible that if one overlaid the strong
cancer resistance conferred by the former, with the increase in stem cell
mobilization and proliferative capacity of the latter, you'd wind up with a
long-lived, slow-aging mouse.
There are a lot of caveats and details both prior and after that statement, many
of which still apply even with these final life span study results. It's not all
completely clear-cut, as is often the case, but I can see this impressive work
garnering a great deal of attention in the popular press once it jumps the
language gap for the English-speaking world.
--
Brian Atkins
Singularity Institute for Artificial Intelligence
http://www.singinst.org/
More information about the tt
mailing list